Lüders Florian, Fürstenberg Torsten, Engelbertz Christiane, Gebauer Katrin, Meyborg Matthias, Malyar Nasser M, Reinecke Holger
1 Division of Vascular Medicine, Department of Cardiovascular Medicine, University Hospital Muenster, Muenster, Germany.
2 Institute for Health and Social research (IGES) Berlin, Berlin, Germany.
Angiology. 2017 Feb;68(2):145-150. doi: 10.1177/0003319716638797. Epub 2016 Jul 11.
Peripheral arterial disease (PAD) and chronic kidney disease (CKD) are major public health problems worldwide. Evaluations of large-scale data on morbidity, outcome, and costs in patients having PAD with CKD are essential. Cross-sectional nationwide population-based analysis of all hospitalizations for PAD during 2009 in Germany focused on the stage-related impact of CKD on morbidity, in-hospital mortality, amputations, length of hospital stay, and health-related expenditure. The total number of hospitalizations was 483 961. Of those, 132 993 (27.5%) had CKD. Chronic kidney disease caused 1.8-fold higher amputation rate ( P < .001) with a stepwise increasing rate with higher CKD stage. Chronic kidney disease doubled in-hospital mortality of patients with PAD (7.8%; n = 10 421) versus 4.0% (n = 14 174, P < .001) with a stepwise increasing risk with higher CKD stage ( P < .001). The highest in-hospital mortality occurred in patients with coprevalence of CKD stage 4 and Fontaine stage IV (16.4%, n = 1176, P < .001). Chronic kidney disease caused 15% higher costs and 21% increased length of stay compared to the whole PAD cohort. This analysis demonstrates the stage-related influence of CKD on morbidity, in-hospital mortality, amputations, length of hospital stay, and reimbursement costs of hospitalized patients with PAD.
外周动脉疾病(PAD)和慢性肾脏病(CKD)是全球主要的公共卫生问题。评估患有PAD合并CKD患者的发病率、结局和成本的大规模数据至关重要。基于德国全国人口的横断面分析,聚焦于2009年所有PAD住院病例,重点关注CKD对发病率、住院死亡率、截肢、住院时间和健康相关支出的分期相关影响。住院总数为483961例。其中,132993例(27.5%)患有CKD。慢性肾脏病导致截肢率高出1.8倍(P <.001),且随着CKD分期升高呈逐步上升趋势。慢性肾脏病使PAD患者的住院死亡率翻倍(7.8%;n = 10421),而无CKD的患者为4.0%(n = 14174,P <.001),且随着CKD分期升高风险逐步增加(P <.001)。住院死亡率最高的是同时患有CKD 4期和Fontaine Ⅳ期的患者(16.4%,n = 1176,P <.001)。与整个PAD队列相比,慢性肾脏病导致成本高出15%,住院时间增加21%。该分析证明了CKD对PAD住院患者的发病率、住院死亡率、截肢、住院时间和报销成本的分期相关影响。